Residual Quantitative Flow Ratio to Estimate Post-Percutaneous Coronary Intervention Fractional Flow Reserve.
Journal
Journal of interventional cardiology
ISSN: 1540-8183
Titre abrégé: J Interv Cardiol
Pays: United States
ID NLM: 8907826
Informations de publication
Date de publication:
2021
2021
Historique:
received:
20
07
2021
accepted:
16
08
2021
entrez:
22
9
2021
pubmed:
23
9
2021
medline:
26
11
2021
Statut:
epublish
Résumé
Quantitative flow ratio (QFR) computes fractional flow reserve (FFR) based on invasive coronary angiography (ICA). Residual QFR estimates post-percutaneous coronary intervention (PCI) FFR. This study sought to assess the relationship of residual QFR with post-PCI FFR. Residual QFR analysis, using pre-PCI ICA, was attempted in 159 vessels with post-PCI FFR. QFR lesion location was matched with the PCI location to simulate the performed intervention and allow computation of residual QFR. A post-PCI FFR < 0.90 was used to define a suboptimal PCI result. Residual QFR computation was successful in 128 (81%) vessels. Median residual QFR was higher than post-PCI FFR (0.96 Q1-Q3: 0.91-0.99 vs. 0.91 Q1-Q3: 0.86-0.96, A significant correlation and agreement between residual QFR and post-PCI FFR were observed. Residual QFR ≥ 0.90 did not necessarily commensurate with a satisfactory PCI (post-PCI FFR ≥ 0.90). In contrast, residual QFR exhibited a high specificity for prediction of a suboptimal PCI result.
Identifiants
pubmed: 34548847
doi: 10.1155/2021/4339451
pmc: PMC8426071
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
4339451Informations de copyright
Copyright © 2021 Pepijn A. van Diemen et al.
Déclaration de conflit d'intérêts
Dr. Knaapen has received research grants from HeartFlow. All other authors declare that they have no conflicts of interest.
Références
Catheter Cardiovasc Interv. 2019 Nov 1;94(5):693-701
pubmed: 30963676
Catheter Cardiovasc Interv. 2020 Nov;96(6):1145-1153
pubmed: 31763775
JACC Cardiovasc Imaging. 2020 Sep;13(9):1976-1985
pubmed: 32305469
JAMA Cardiol. 2017 Oct 1;2(10):1100-1107
pubmed: 28813561
J Am Coll Cardiol. 2014 Oct 21;64(16):1641-54
pubmed: 25323250
JACC Cardiovasc Interv. 2020 Jul 27;13(14):1639-1650
pubmed: 32703590
JACC Cardiovasc Interv. 2016 Oct 10;9(19):2024-2035
pubmed: 27712739
N Engl J Med. 2009 Jan 15;360(3):213-24
pubmed: 19144937
J Am Coll Cardiol. 2017 Dec 26;70(25):3077-3087
pubmed: 29101020
JACC Cardiovasc Interv. 2016 May 23;9(10):1022-31
pubmed: 27198682
JACC Cardiovasc Interv. 2018 Oct 22;11(20):2099-2109
pubmed: 30336814
Circ Cardiovasc Imaging. 2018 May;11(5):e007417
pubmed: 29703779
Circulation. 2019 Jan 29;139(5):694-706
pubmed: 30689413
Am Heart J. 2017 Jan;183:1-9
pubmed: 27979031
Circ Cardiovasc Interv. 2019 May;12(5):e007428
pubmed: 31018666
Circulation. 2002 Jun 25;105(25):2950-4
pubmed: 12081986
Am Heart J. 2017 Feb;184:10-16
pubmed: 27892882
J Invasive Cardiol. 2020 Nov;32(11):E268-E276
pubmed: 32911462
Circ Cardiovasc Imaging. 2018 Mar;11(3):e007107
pubmed: 29555835
JAMA Cardiol. 2019 Apr 1;4(4):370-374
pubmed: 30840026
Circ Cardiovasc Interv. 2021 Mar;14(3):e009681
pubmed: 33685214
JACC Cardiovasc Interv. 2020 Aug 24;13(16):1920-1933
pubmed: 32819481
Eur Heart J. 2020 Jan 14;41(3):407-477
pubmed: 31504439
EuroIntervention. 2018 Dec 20;14(12):e1324-e1331
pubmed: 29784630
Circ Cardiovasc Interv. 2017 Aug;10(8):
pubmed: 28790165
JACC Cardiovasc Interv. 2021 Feb 8;14(3):237-246
pubmed: 33541534
Eur Heart J. 2019 Jan 7;40(2):180-186
pubmed: 30596995
N Engl J Med. 2018 Jul 19;379(3):250-259
pubmed: 29785878